July 12, 2021
NineSigma, on behalf of Daiichi Sankyo Co., Ltd., seeks novel drug targets or seeds, which are related to the cancer-neuron axis, an interaction between the nervous system and tumour. Recent studies suggest that the nervous system including nerve cells and neural factors exaggerates cancer cell growth in the tumour microenvironment (Trends […]